Techfields Inc. (Techfields Pharma) is a late stage clinical pharmaceutical company focused on a completely new direction of drug development for inflammatory diseases, autoimmune diseases, cardiovascular diseases, metabolic diseases, depression, and age-related diseases. Our novel transdermal drug delivery platform allows drugs to penetrate skin, blood-brain, blood-milk, and other biological membrane barriers much faster with stronger pharmaceutical efficacy than their parent drugs, making previously untreatable diseases treatable. Our foundational technology allows all types of medicines to be delivered through the skin. This allows for better penetration into target tissues, potentially allowing for lower dosing and less side effects as seen with oral preparations. This would improve the clinical effect while improving the overall safety profile. Our transdermal delivery platform allows drugs to penetrate many times faster than if the medication were given orally. Effective drug concentrations at the targeted treatment site(s) can be maintained for extended periods of time enhancing therapeutic effect.



Techfields continues to advance novel small molecule compounds to create new solutions with unmet medical needs. Techfields utilizes advanced technologies to enhance its drug discovery capabilities and to accelerate the drug development process. Live a "Better Life" with Techfields.